Pharming Group N.V.

PHGUF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$7,467$7,079-$11,788$6,678
Dep. & Amort.$2,714$2,702$2,582$7,699
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$3,476$2,576$2,643
Change in WC$9,032-$1,390$1,419-$7,085
Other Non-Cash$10,797-$124$5,443-$604
Operating Cash Flow$30,010$11,743$232$9,331
Investing Activities
PP&E Inv.-$69-$128-$288-$136
Net Acquisitions-$1,666-$18-$57,887$0
Inv. Purchases-$302$0-$422-$62,065
Inv. Sales/Matur.-$308$17,101$67,866$52,411
Other Inv. Act.$0$0$422$0
Investing Cash Flow-$2,345$16,955$9,691-$9,790
Financing Activities
Debt Repay.$0-$1,066-$715-$1,516
Stock Issued$13,327$1,118$248$2,021
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1,379-$2,809-$6,252-$2,709
Financing Cash Flow$11,948-$2,757-$6,719-$2,204
Forex Effect-$1,370$6,057$1,945-$3,055
Net Chg. in Cash$38,243$31,998$5,149-$5,718
Supplemental Information
Beg. Cash$94,817$60,093$54,944$60,662
End Cash$133,060$92,091$60,093$54,944
Free Cash Flow$29,941$11,615-$56$9,195
Pharming Group N.V. (PHGUF) Financial Statements & Key Stats | AlphaPilot